202 related articles for article (PubMed ID: 38295461)
1. Role of genetically engineered mesenchymal stem cell exosomes and LncRNAs in respiratory diseases treatment.
Jasim SA; Aziz DZ; Mustafa YF; Margiana R; Al-Alwany AA; Hjazi A; Alawadi A; Yumashev A; Alsalamy A; Fenjan MN
Pathol Res Pract; 2024 Feb; 254():155135. PubMed ID: 38295461
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
Hezam K; Mo R; Wang C; Liu Y; Li Z
Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.
Bari E; Ferrarotti I; Torre ML; Corsico AG; Perteghella S
J Control Release; 2019 Sep; 309():11-24. PubMed ID: 31326462
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases.
Műzes G; Sipos F
Cells; 2022 Jul; 11(15):. PubMed ID: 35892597
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Cells; 2019 May; 8(5):. PubMed ID: 31100966
[TBL] [Abstract][Full Text] [Related]
6. Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment.
Zhai Z; Cui T; Chen J; Mao X; Zhang T
J Transl Med; 2023 Dec; 21(1):895. PubMed ID: 38071321
[TBL] [Abstract][Full Text] [Related]
7. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model.
Khatri M; Richardson LA; Meulia T
Stem Cell Res Ther; 2018 Jan; 9(1):17. PubMed ID: 29378639
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications.
Gemayel J; Chaker D; El Hachem G; Mhanna M; Salemeh R; Hanna C; Harb F; Ibrahim A; Chebly A; Khalil C
Clin Transl Oncol; 2023 Jul; 25(7):2056-2068. PubMed ID: 36808392
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis.
Zheng G; Huang R; Qiu G; Ge M; Wang J; Shu Q; Xu J
Cell Tissue Res; 2018 Oct; 374(1):1-15. PubMed ID: 29955951
[TBL] [Abstract][Full Text] [Related]
13. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.
Lin H; Chen H; Zhao X; Chen Z; Zhang P; Tian Y; Wang Y; Ding T; Wang L; Shen Y
J Transl Med; 2021 Nov; 19(1):456. PubMed ID: 34736500
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics.
Wang S; Lei B; Zhang E; Gong P; Gu J; He L; Han L; Yuan Z
Int J Nanomedicine; 2022; 17():1757-1781. PubMed ID: 35469174
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
Gupta A; Kashte S; Gupta M; Rodriguez HC; Gautam SS; Kadam S
Hum Cell; 2020 Oct; 33(4):907-918. PubMed ID: 32780299
[TBL] [Abstract][Full Text] [Related]
18. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases.
Shen Z; Huang W; Liu J; Tian J; Wang S; Rui K
Front Immunol; 2021; 12():749192. PubMed ID: 34646275
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
